Note: This free educational session does not provide ACRP Contact Hours.
Alexandra Moens, PharmD, Director of Product Marketing, H1
Stacey Rivkin, VP, Strategic Client Solutions, H1
Health equity requires every moving piece of the healthcare ecosystem, including pharma companies. But ensuring a more equitable and accessible healthcare system starts for pharma at the beginning. It starts with the HCPs you engage for pre-drug launch and marketing; it starts with the site investigators you recruit; it starts with the location and availability of the study. It comes down to a basic ABC(D) equation. D=diversity.
In this informative event we’ll explore:
Historically, what has been lacking in clinical trials when it comes to diversity and inclusion
Why it took federal guidelines to begin to turn the conversation toward pharma and health equity
How big data can fuel trial diversity and why the data matters as well as a case study
What the ABC(and D’s) are of clinical trial diversity, equity, access, and inclusion
Why geography and patient representation matter
By registering, you agree to have your contact information, including email, provided the sponsors of this event for the purpose of following up on your interests.